IndicatorCode,Indicator,ValueType,ParentLocationCode,ParentLocation,Location type,SpatialDimValueCode,Location,Period type,Period,IsLatestYear,Dim1 type,Dim1,Dim1ValueCode,Dim2 type,Dim2,Dim2ValueCode,Dim3 type,Dim3,Dim3ValueCode,DataSourceDimValueCode,DataSource,FactValueNumericPrefix,FactValueNumeric,FactValueUoM,FactValueNumericLowPrefix,FactValueNumericLow,FactValueNumericHighPrefix,FactValueNumericHigh,Value,FactValueTranslationID,FactComments,Language,DateModified
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BEN,Benin,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,0,0 [0-0],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BEN,Benin,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,0,,,0,,0,0 [0-0],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BEN,Benin,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,0,,,0,,0,0 [0-0],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ETH,Ethiopia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,0,0 [0-0],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,TLS,Timor-Leste,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,0,0 [0-0],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BEN,Benin,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,0,,,0,,1,0 [0-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CIV,Cote d'Ivoire,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,1,0 [0-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,FJI,Fiji,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,1,0 [0-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GNB,Guinea-Bissau,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,1,0 [0-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,NER,Niger,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,1,0 [0-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,SLB,Solomon Islands,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,1,0 [0-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SOM,Somalia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,1,0 [0-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SDN,Sudan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,1,0 [0-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,TLS,Timor-Leste,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,0,,,0,,1,0 [0-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CAF,Central African Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,2,0 [0-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,TCD,Chad,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,2,0 [0-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GMB,Gambia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,2,0 [0-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SSD,South Sudan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,0,,,0,,2,0 [0-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CIV,Cote d'Ivoire,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,1,,,0,,1,1 [0-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,PHL,Philippines,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,1,1 [0-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SDN,Sudan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,1,,,0,,1,1 [0-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,TLS,Timor-Leste,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,1,,,0,,1,1 [0-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BFA,Burkina Faso,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,2,1 [0-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BDI,Burundi,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,2,1 [0-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,DJI,Djibouti,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,2,1 [0-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ERI,Eritrea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,2,1 [0-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MOZ,Mozambique,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,2,1 [0-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,MMR,Myanmar,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,2,1 [0-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,PNG,Papua New Guinea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,2,1 [0-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,VUT,Vanuatu,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,2,1 [0-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,YEM,Yemen,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,2,1 [0-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,COD,Democratic Republic of the Congo,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,3,1 [0-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,LBR,Liberia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,3,1 [0-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SLE,Sierra Leone,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,3,1 [0-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GIN,Guinea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,0,,4,1 [0-4],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,BGD,Bangladesh,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CIV,Cote d'Ivoire,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CIV,Cote d'Ivoire,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CMR,Cameroon,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,EGY,Egypt,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,EGY,Egypt,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,EGY,Egypt,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,EGY,Egypt,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GAB,Gabon,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MDG,Madagascar,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,PAK,Pakistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,PAK,Pakistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,PAK,Pakistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,PAK,Pakistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,PHL,Philippines,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,PHL,Philippines,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,PHL,Philippines,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SOM,Somalia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SDN,Sudan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SDN,Sudan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,TLS,Timor-Leste,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,1,,,1,,1,1 [1-1],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SOM,Somalia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,1,,,1,,2,1 [1-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MUS,Mauritius,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,10,,,10,,11,10 [10-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,KGZ,Kyrgyzstan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,10,,,4,,16,10 [4-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,TUV,Tuvalu,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,10,,,4,,17,10 [4-17],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,VNM,Viet Nam,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,10,,,5,,15,10 [5-15],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,BHR,Bahrain,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,10,,,5,,18,10 [5-18],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,KHM,Cambodia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,10,,,6,,14,10 [6-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SSD,South Sudan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,10,,,6,,14,10 [6-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,YEM,Yemen,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,10,,,6,,14,10 [6-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BDI,Burundi,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,10,,,6,,15,10 [6-15],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GIN,Guinea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,10,,,6,,16,10 [6-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,RWA,Rwanda,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,10,,,6,,17,10 [6-17],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,DZA,Algeria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,10,,,7,,13,10 [7-13],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,AFG,Afghanistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,10,,,7,,14,10 [7-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,NER,Niger,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,10,,,7,,14,10 [7-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ERI,Eritrea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,10,,,7,,15,10 [7-15],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,TGO,Togo,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,10,,,7,,16,10 [7-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,UZB,Uzbekistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,10,,,8,,12,10 [8-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,BRN,Brunei Darussalam,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,10,,,9,,10,10 [9-10],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,NPL,Nepal,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,10,,,9,,10,10 [9-10],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,AZE,Azerbaijan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,10,,,9,,11,10 [9-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,AZE,Azerbaijan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,10,,,9,,11,10 [9-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,COM,Comoros,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,10,,,9,,11,10 [9-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,HTI,Haiti,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,10,,,9,,11,10 [9-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,JOR,Jordan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,10,,,9,,11,10 [9-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SEN,Senegal,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,10,,,9,,11,10 [9-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,UGA,Uganda,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,10,,,9,,11,10 [9-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,COM,Comoros,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,10,,,9,,13,10 [9-13],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SWE,Sweden,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,100,,,97,,102,100 [97-102],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,AZE,Azerbaijan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,11,,,10,,12,11 [10-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,IRQ,Iraq,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,11,,,10,,12,11 [10-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,JOR,Jordan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,11,,,10,,12,11 [10-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,KAZ,Kazakhstan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,11,,,10,,12,11 [10-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,LSO,Lesotho,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,11,,,10,,12,11 [10-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,UZB,Uzbekistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,11,,,10,,13,11 [10-13],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,LBN,Lebanon,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,11,,,7,,15,11 [7-15],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,TZA,United Republic of Tanzania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,11,,,7,,16,11 [7-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,NGA,Nigeria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,11,,,7,,17,11 [7-17],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GNB,Guinea-Bissau,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,11,,,8,,15,11 [8-15],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GMB,Gambia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,11,,,8,,16,11 [8-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SLE,Sierra Leone,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,11,,,8,,16,11 [8-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,FSM,Micronesia (Federated States of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,11,,,9,,12,11 [9-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,TJK,Tajikistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,11,,,9,,12,11 [9-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MNE,Montenegro,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,11,,,9,,13,11 [9-13],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SRB,Serbia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,11,,,9,,14,11 [9-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,DZA,Algeria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,12,,,10,,14,12 [10-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,IDN,Indonesia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,12,,,10,,14,12 [10-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SWZ,Eswatini,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,12,,,10,,15,12 [10-15],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,SLB,Solomon Islands,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,12,,,11,,12,12 [11-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,IRQ,Iraq,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,12,,,11,,13,12 [11-13],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ZWE,Zimbabwe,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,12,,,11,,13,12 [11-13],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BRA,Brazil,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,12,,,12,,12,12 [12-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,JOR,Jordan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,12,,,12,,12,12 [12-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,FSM,Micronesia (Federated States of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,12,,,12,,13,12 [12-13],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SYC,Seychelles,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,12,,,6,,19,12 [6-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GAB,Gabon,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,12,,,6,,20,12 [6-20],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GNQ,Equatorial Guinea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,12,,,7,,18,12 [7-18],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,NAM,Namibia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,12,,,7,,18,12 [7-18],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,VUT,Vanuatu,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,12,,,7,,19,12 [7-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,RWA,Rwanda,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,12,,,7,,21,12 [7-21],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,LBR,Liberia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,12,,,8,,17,12 [8-17],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,PSE,"occupied Palestinian territory, including east Jerusalem",Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,12,,,8,,17,12 [8-17],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ZMB,Zambia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,12,,,9,,16,12 [9-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,KWT,Kuwait,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,13,,,10,,16,13 [10-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,TUN,Tunisia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,13,,,10,,16,13 [10-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,KIR,Kiribati,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,13,,,10,,17,13 [10-17],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,KEN,Kenya,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,13,,,11,,14,13 [11-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,COG,Congo,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,13,,,11,,16,13 [11-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,LVA,Latvia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,13,,,12,,14,13 [12-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,TJK,Tajikistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,13,,,12,,14,13 [12-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,UZB,Uzbekistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,13,,,12,,14,13 [12-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,WSM,Samoa,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,13,,,6,,21,13 [6-21],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,MNG,Mongolia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,13,,,7,,19,13 [7-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GIN,Guinea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,13,,,8,,20,13 [8-20],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,CHN,China,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,13,,,9,,15,13 [9-15],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,STP,Sao Tome and Principe,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,13,,,9,,16,13 [9-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,KHM,Cambodia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,13,,,9,,19,13 [9-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,TZA,United Republic of Tanzania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,13,,,9,,19,13 [9-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,TGO,Togo,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,13,,,9,,20,13 [9-20],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,AGO,Angola,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,14,,,10,,20,14 [10-20],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SAU,Saudi Arabia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,14,,,11,,17,14 [11-17],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,DZA,Algeria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,14,,,12,,15,14 [12-15],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BIH,Bosnia and Herzegovina,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,14,,,12,,15,14 [12-15],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,GUY,Guyana,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,14,,,12,,17,14 [12-17],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,LSO,Lesotho,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,14,,,13,,15,14 [13-15],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,COK,Cook Islands,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,14,,,7,,23,14 [7-23],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,BTN,Bhutan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,14,,,8,,20,14 [8-20],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,LBY,Libya,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,14,,,9,,19,14 [9-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,NGA,Nigeria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,14,,,9,,21,14 [9-21],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,QAT,Qatar,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,14,,,9,,21,14 [9-21],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,AFG,Afghanistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,15,,,10,,20,15 [10-20],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,LKA,Sri Lanka,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,15,,,10,,21,15 [10-21],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,PSE,"occupied Palestinian territory, including east Jerusalem",Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,15,,,11,,22,15 [11-22],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,COG,Congo,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,15,,,12,,18,15 [12-18],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MWI,Malawi,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,15,,,12,,18,15 [12-18],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,TUN,Tunisia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,15,,,12,,18,15 [12-18],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,KWT,Kuwait,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,15,,,13,,17,15 [13-17],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,LBN,Lebanon,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,15,,,13,,17,15 [13-17],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SWZ,Eswatini,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,15,,,13,,18,15 [13-18],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,DZA,Algeria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,15,,,14,,16,15 [14-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GNQ,Equatorial Guinea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,15,,,8,,23,15 [8-23],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,SUR,Suriname,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,15,,,8,,23,15 [8-23],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,PRK,Democratic People's Republic of Korea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,15,,,9,,23,15 [9-23],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,FJI,Fiji,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,16,,,13,,19,16 [13-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,GEO,Georgia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,16,,,13,,19,16 [13-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,KIR,Kiribati,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,16,,,13,,19,16 [13-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,TUN,Tunisia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,16,,,13,,19,16 [13-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,KWT,Kuwait,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,16,,,14,,18,16 [14-18],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,PER,Peru,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,16,,,15,,16,16 [15-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,SLB,Solomon Islands,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,16,,,15,,16,16 [15-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ARM,Armenia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,16,,,15,,18,16 [15-18],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,TUR,Türkiye,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,16,,,16,,16,16 [16-16],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,KHM,Cambodia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,17,,,12,,24,17 [12-24],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,THA,Thailand,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,17,,,13,,24,17 [13-24],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ZMB,Zambia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,17,,,14,,19,17 [14-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,COG,Congo,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,17,,,14,,22,17 [14-22],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,KEN,Kenya,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,17,,,15,,18,17 [15-18],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,KWT,Kuwait,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,17,,,15,,19,17 [15-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,LSO,Lesotho,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,17,,,16,,17,17 [16-17],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,LBN,Lebanon,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,17,,,16,,18,17 [16-18],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,MAR,Morocco,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,17,,,16,,18,17 [16-18],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,NIU,Niue,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,17,,,9,,26,17 [9-26],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,TUV,Tuvalu,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,18,,,14,,23,18 [14-23],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,KIR,Kiribati,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,18,,,15,,21,18 [15-21],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ZWE,Zimbabwe,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,18,,,16,,19,18 [16-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,GUY,Guyana,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,18,,,16,,20,18 [16-20],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,MAR,Morocco,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,18,,,16,,20,18 [16-20],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,MAR,Morocco,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,18,,,16,,22,18 [16-22],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CPV,Cabo Verde,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,18,,,17,,20,18 [17-20],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,FIN,Finland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,18,,,18,,19,18 [18-19],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,LBY,Libya,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,19,,,12,,26,19 [12-26],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,AFG,Afghanistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,19,,,13,,26,19 [13-26],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SAU,Saudi Arabia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,19,,,14,,26,19 [14-26],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,PSE,"occupied Palestinian territory, including east Jerusalem",Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,19,,,14,,27,19 [14-27],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,MYS,Malaysia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,19,,,15,,23,19 [15-23],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SWZ,Eswatini,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,19,,,16,,21,19 [16-21],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MWI,Malawi,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,19,,,17,,21,19 [17-21],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ZWE,Zimbabwe,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,19,,,17,,21,19 [17-21],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,LBN,Lebanon,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,19,,,18,,20,19 [18-20],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,AFG,Afghanistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,0,,4,2 [0-4],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GNQ,Equatorial Guinea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,0,,5,2 [0-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,NGA,Nigeria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,0,,5,2 [0-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,RWA,Rwanda,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,0,,5,2 [0-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,STP,Sao Tome and Principe,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,0,,5,2 [0-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SEN,Senegal,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,0,,5,2 [0-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,IND,India,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,1,,2,2 [1-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GHA,Ghana,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,1,,3,2 [1-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,LAO,Lao People's Democratic Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,1,,3,2 [1-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MRT,Mauritania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,1,,3,2 [1-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SYR,Syrian Arab Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,1,,3,2 [1-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MUS,Mauritius,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,1,,4,2 [1-4],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,KHM,Cambodia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,1,,5,2 [1-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,UGA,Uganda,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,1,,5,2 [1-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,TGO,Togo,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,1,,6,2 [1-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ETH,Ethiopia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,2,,,2,,2,2 [2-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,HTI,Haiti,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,2,,2,2 [2-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,IND,India,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,2,,,2,,2,2 [2-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,IND,India,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,2,,,2,,2,2 [2-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,IND,India,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,2,,,2,,2,2 [2-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SOM,Somalia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,2,,,2,,2,2 [2-2],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,IDN,Indonesia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,2,,3,2 [2-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MOZ,Mozambique,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,2,,,2,,3,2 [2-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,MMR,Myanmar,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,2,,,2,,3,2 [2-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,NPL,Nepal,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,2,,,2,,3,2 [2-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,PNG,Papua New Guinea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,2,,,2,,3,2 [2-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BWA,Botswana,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,20,,,13,,27,20 [13-27],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,AGO,Angola,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,20,,,14,,28,20 [14-28],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,VNM,Viet Nam,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,20,,,16,,23,20 [16-23],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,STP,Sao Tome and Principe,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,20,,,17,,23,20 [17-23],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,MHL,Marshall Islands,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,20,,,17,,24,20 [17-24],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,GEO,Georgia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,20,,,18,,22,20 [18-22],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ZMB,Zambia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,20,,,18,,22,20 [18-22],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ZWE,Zimbabwe,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,20,,,18,,22,20 [18-22],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MDA,Republic of Moldova,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,20,,,19,,22,20 [19-22],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,BHR,Bahrain,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,21,,,13,,31,21 [13-31],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,LKA,Sri Lanka,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,21,,,15,,26,21 [15-26],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SYC,Seychelles,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,21,,,15,,29,21 [15-29],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BOL,Bolivia (Plurinational State of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,21,,,16,,26,21 [16-26],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,KGZ,Kyrgyzstan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,22,,,16,,28,22 [16-28],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ZAF,South Africa,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,22,,,17,,29,22 [17-29],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,TUV,Tuvalu,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,22,,,18,,26,22 [18-26],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,GUY,Guyana,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,22,,,21,,24,22 [21-24],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,LBY,Libya,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,23,,,15,,32,23 [15-32],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,NAM,Namibia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,23,,,18,,28,23 [18-28],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,ARE,United Arab Emirates,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,23,,,19,,28,23 [19-28],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,GEO,Georgia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,23,,,22,,25,23 [22-25],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,WSM,Samoa,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,24,,,14,,36,24 [14-36],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,LKA,Sri Lanka,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,24,,,18,,29,24 [18-29],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BLZ,Belize,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,24,,,18,,33,24 [18-33],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,TTO,Trinidad and Tobago,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,24,,,22,,26,24 [22-26],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,VEN,Venezuela (Bolivarian Republic of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,25,,,16,,34,25 [16-34],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,AGO,Angola,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,25,,,18,,35,25 [18-35],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MUS,Mauritius,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,25,,,20,,31,25 [20-31],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,PLW,Palau,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,25,,,22,,27,25 [22-27],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,VNM,Viet Nam,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,25,,,22,,28,25 [22-28],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MKD,North Macedonia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,26,,,18,,35,26 [18-35],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SMR,San Marino,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,26,,,18,,35,26 [18-35],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,SUR,Suriname,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,26,,,18,,35,26 [18-35],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SYC,Seychelles,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,26,,,19,,35,26 [19-35],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,JAM,Jamaica,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,26,,,21,,31,26 [21-31],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BIH,Bosnia and Herzegovina,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,26,,,23,,29,26 [23-29],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,AUS,Australia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,26,,,24,,28,26 [24-28],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,BRN,Brunei Darussalam,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,26,,,25,,27,26 [25-27],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,DNK,Denmark,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,26,,,25,,27,26 [25-27],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,KOR,Republic of Korea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,26,,,25,,28,26 [25-28],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,NRU,Nauru,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,27,,,18,,37,27 [18-37],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,BHR,Bahrain,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,27,,,18,,39,27 [18-39],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,LKA,Sri Lanka,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,27,,,21,,33,27 [21-33],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MNE,Montenegro,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,27,,,23,,32,27 [23-32],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,VCT,Saint Vincent and the Grenadines,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,27,,,25,,28,27 [25-28],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,STP,Sao Tome and Principe,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,27,,,25,,29,27 [25-29],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,NOR,Norway,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,27,,,26,,28,27 [26-28],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ISR,Israel,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,27,,,27,,28,27 [27-28],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,URY,Uruguay,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,27,,,27,,28,27 [27-28],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,TUV,Tuvalu,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,28,,,25,,31,28 [25-31],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ISL,Iceland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,28,,,25,,32,28 [25-32],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,CHN,China,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,28,,,26,,30,28 [26-30],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BGR,Bulgaria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,28,,,27,,28,28 [27-28],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,WSM,Samoa,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,29,,,18,,43,29 [18-43],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,PRK,Democratic People's Republic of Korea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,29,,,20,,41,29 [20-41],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,ECU,Ecuador,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,29,,,21,,36,29 [21-36],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,IRN,Iran (Islamic Republic of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,29,,,21,,37,29 [21-37],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,NAM,Namibia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,29,,,25,,33,29 [25-33],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,ARE,United Arab Emirates,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,29,,,25,,33,29 [25-33],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ARM,Armenia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,29,,,27,,31,29 [27-31],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,NZL,New Zealand,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,29,,,28,,29,29 [28-29],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,GRD,Grenada,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,29,,,28,,30,29 [28-30],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,CHN,China,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,29,,,28,,31,29 [28-31],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MWI,Malawi,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,3,,,0,,6,3 [0-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MLI,Mali,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,3,,,1,,4,3 [1-4],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,AGO,Angola,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,3,,,1,,7,3 [1-7],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,TZA,United Republic of Tanzania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,3,,,1,,7,3 [1-7],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,KEN,Kenya,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,3,,,2,,3,3 [2-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,LAO,Lao People's Democratic Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,3,,,2,,3,3 [2-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MOZ,Mozambique,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,3,,,2,,3,3 [2-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GHA,Ghana,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,3,,,2,,4,3 [2-4],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GHA,Ghana,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,3,,,2,,4,3 [2-4],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,LAO,Lao People's Democratic Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,3,,,2,,5,3 [2-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,MDV,Maldives,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,3,,,2,,5,3 [2-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,TON,Tonga,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,3,,,2,,5,3 [2-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ETH,Ethiopia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,3,,,3,,3,3 [3-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MDG,Madagascar,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,3,,,3,,3,3 [3-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MOZ,Mozambique,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,3,,,3,,3,3 [3-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,MMR,Myanmar,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,3,,,3,,3,3 [3-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,PNG,Papua New Guinea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,3,,,3,,3,3 [3-3],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BIH,Bosnia and Herzegovina,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,3,,,3,,4,3 [3-4],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GHA,Ghana,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,3,,,3,,4,3 [3-4],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,GTM,Guatemala,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,30,,,22,,40,30 [22-40],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,IRL,Ireland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,30,,,23,,37,30 [23-37],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,BTN,Bhutan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,30,,,23,,38,30 [23-38],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,FJI,Fiji,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,31,,,20,,42,31 [20-42],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,NIU,Niue,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,31,,,21,,43,31 [21-43],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,QAT,Qatar,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,31,,,24,,39,31 [24-39],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,CHN,China,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,31,,,29,,33,31 [29-33],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,EST,Estonia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,31,,,30,,33,31 [30-33],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SVN,Slovenia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,31,,,31,,32,31 [31-32],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,VNM,Viet Nam,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,31,,,31,,32,31 [31-32],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,SUR,Suriname,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,32,,,22,,41,32 [22-41],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SYC,Seychelles,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,32,,,23,,44,32 [23-44],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,ATG,Antigua and Barbuda,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,32,,,24,,41,32 [24-41],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BWA,Botswana,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,32,,,26,,38,32 [26-38],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,BRN,Brunei Darussalam,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,32,,,30,,33,32 [30-33],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,KAZ,Kazakhstan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,32,,,30,,34,32 [30-34],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,TKM,Turkmenistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,33,,,28,,38,33 [28-38],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,KGZ,Kyrgyzstan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,33,,,28,,39,33 [28-39],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ROU,Romania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,33,,,31,,35,33 [31-35],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,SGP,Singapore,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,33,,,31,,35,33 [31-35],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,DMA,Dominica,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,33,,,31,,36,33 [31-36],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,MHL,Marshall Islands,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,34,,,28,,39,34 [28-39],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,ARE,United Arab Emirates,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,34,,,28,,40,34 [28-40],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,LTU,Lithuania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,34,,,31,,37,34 [31-37],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ARM,Armenia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,34,,,32,,36,34 [32-36],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ZAF,South Africa,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,34,,,32,,37,34 [32-37],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BRA,Brazil,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,34,,,34,,35,34 [34-35],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BHS,Bahamas,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,35,,,27,,44,35 [27-44],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,LCA,Saint Lucia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,35,,,32,,38,35 [32-38],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,WSM,Samoa,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,36,,,22,,51,36 [22-51],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,PRK,Democratic People's Republic of Korea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,36,,,25,,48,36 [25-48],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BIH,Bosnia and Herzegovina,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,36,,,30,,44,36 [30-44],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,GBR,United Kingdom of Great Britain and Northern Ireland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,36,,,31,,40,36 [31-40],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,FRA,France,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,36,,,32,,40,36 [32-40],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,HND,Honduras,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,36,,,32,,40,36 [32-40],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,CYP,Cyprus,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,36,,,34,,38,36 [34-38],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,COK,Cook Islands,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,37,,,24,,50,37 [24-50],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,BHR,Bahrain,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,37,,,24,,52,37 [24-52],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BLR,Belarus,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,37,,,29,,45,37 [29-45],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,MNG,Mongolia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,37,,,30,,42,37 [30-42],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ALB,Albania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,37,,,30,,44,37 [30-44],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,NIU,Niue,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,38,,,26,,51,38 [26-51],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MNE,Montenegro,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,38,,,30,,46,38 [30-46],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,ARE,United Arab Emirates,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,38,,,30,,50,38 [30-50],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,MHL,Marshall Islands,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,38,,,32,,44,38 [32-44],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,IRN,Iran (Islamic Republic of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,38,,,33,,44,38 [33-44],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CPV,Cabo Verde,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,38,,,35,,41,38 [35-41],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ROU,Romania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,38,,,36,,40,38 [36-40],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SVK,Slovakia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,38,,,36,,40,38 [36-40],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,MEX,Mexico,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,38,,,37,,39,38 [37-39],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BEL,Belgium,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,38,,,38,,39,38 [38-39],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,VEN,Venezuela (Bolivarian Republic of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,39,,,29,,50,39 [29-50],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BWA,Botswana,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,39,,,34,,44,39 [34-44],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ARM,Armenia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,39,,,37,,42,39 [37-42],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,NAM,Namibia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,39,,,37,,42,39 [37-42],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,UKR,Ukraine,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,39,,,38,,40,39 [38-40],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,TJK,Tajikistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,4,,,1,,7,4 [1-7],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,LBY,Libya,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,4,,,1,,9,4 [1-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,PSE,"occupied Palestinian territory, including east Jerusalem",Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,4,,,1,,9,4 [1-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,DJI,Djibouti,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,4,,,2,,6,4 [2-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CMR,Cameroon,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,4,,,3,,4,4 [3-4],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,MMR,Myanmar,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,4,,,3,,4,4 [3-4],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,PNG,Papua New Guinea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,4,,,3,,4,4 [3-4],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SYR,Syrian Arab Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,4,,,3,,4,4 [3-4],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BFA,Burkina Faso,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,4,,,3,,5,4 [3-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,TCD,Chad,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,4,,,3,,5,4 [3-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MLI,Mali,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,4,,,3,,5,4 [3-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,LAO,Lao People's Democratic Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,4,,,3,,6,4 [3-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CAF,Central African Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,4,,,3,,7,4 [3-7],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ETH,Ethiopia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,4,,,3,,7,4 [3-7],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MRT,Mauritania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,4,,,4,,4,4 [4-4],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GAB,Gabon,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,4,,,4,,5,4 [4-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SYR,Syrian Arab Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,4,,,4,,5,4 [4-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,SUR,Suriname,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,40,,,29,,51,40 [29-51],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,BTN,Bhutan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,40,,,33,,47,40 [33-47],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,KGZ,Kyrgyzstan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,40,,,34,,45,40 [34-45],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BLZ,Belize,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,40,,,34,,47,40 [34-47],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,LVA,Latvia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,40,,,37,,43,40 [37-43],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,JPN,Japan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,40,,,37,,44,40 [37-44],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,MYS,Malaysia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,40,,,38,,42,40 [38-42],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,QAT,Qatar,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,41,,,34,,50,41 [34-50],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,PRY,Paraguay,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,41,,,37,,45,41 [37-45],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,NIC,Nicaragua,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,41,,,37,,46,41 [37-46],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BRA,Brazil,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,41,,,38,,44,41 [38-44],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SRB,Serbia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,41,,,40,,42,41 [40-42],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,PRK,Democratic People's Republic of Korea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,42,,,30,,57,42 [30-57],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MUS,Mauritius,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,42,,,31,,56,42 [31-56],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,NRU,Nauru,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,42,,,35,,50,42 [35-50],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,RUS,Russian Federation,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,42,,,36,,47,42 [36-47],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,POL,Poland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,42,,,39,,45,42 [39-45],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CPV,Cabo Verde,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,42,,,39,,46,42 [39-46],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ROU,Romania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,42,,,40,,45,42 [40-45],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MCO,Monaco,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,43,,,33,,54,43 [33-54],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,NLD,Netherlands (Kingdom of the),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,43,,,35,,51,43 [35-51],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,IRN,Iran (Islamic Republic of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,43,,,38,,48,43 [38-48],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SWE,Sweden,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,43,,,38,,48,43 [38-48],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ZAF,South Africa,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,43,,,40,,47,43 [40-47],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CAN,Canada,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,43,,,42,,44,43 [42-44],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,NIU,Niue,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,44,,,31,,59,44 [31-59],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,PAN,Panama,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,44,,,36,,52,44 [36-52],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ESP,Spain,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,44,,,38,,51,44 [38-51],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,COK,Cook Islands,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,45,,,31,,60,45 [31-60],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,VEN,Venezuela (Bolivarian Republic of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,45,,,34,,57,45 [34-57],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,PRT,Portugal,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,45,,,42,,48,45 [42-48],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,HUN,Hungary,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,45,,,43,,47,45 [43-47],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BOL,Bolivia (Plurinational State of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,46,,,42,,51,46 [42-51],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,SLV,El Salvador,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,46,,,43,,49,46 [43-49],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,TTO,Trinidad and Tobago,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,46,,,43,,49,46 [43-49],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CHL,Chile,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,46,,,45,,47,46 [45-47],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BLZ,Belize,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,47,,,41,,53,47 [41-53],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,MYS,Malaysia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,47,,,42,,52,47 [42-52],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,MNG,Mongolia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,47,,,42,,52,47 [42-52],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,USA,United States of America,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,47,,,45,,49,47 [45-49],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,ECU,Ecuador,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,48,,,41,,55,48 [41-55],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,MHL,Marshall Islands,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,48,,,42,,55,48 [42-55],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,GTM,Guatemala,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,49,,,41,,57,49 [41-57],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ITA,Italy,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,49,,,43,,55,49 [43-55],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MLT,Malta,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,49,,,45,,52,49 [45-52],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,THA,Thailand,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,49,,,45,,53,49 [45-53],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,IRN,Iran (Islamic Republic of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,49,,,45,,54,49 [45-54],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,TUR,Türkiye,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,49,,,48,,50,49 [48-50],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,NER,Niger,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,5,,,3,,7,5 [3-7],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SSD,South Sudan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,5,,,3,,7,5 [3-7],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BDI,Burundi,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,5,,,3,,8,5 [3-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,COD,Democratic Republic of the Congo,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,5,,,3,,8,5 [3-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,VUT,Vanuatu,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,5,,,3,,8,5 [3-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,YEM,Yemen,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,5,,,3,,8,5 [3-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,DJI,Djibouti,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,5,,,3,,9,5 [3-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,BGD,Bangladesh,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,5,,,4,,5,5 [4-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CMR,Cameroon,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,5,,,4,,5,5 [4-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,HTI,Haiti,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,5,,,4,,5,5 [4-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MDG,Madagascar,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,5,,,4,,5,5 [4-5],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,LSO,Lesotho,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,5,,,4,,6,5 [4-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,MDV,Maldives,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,5,,,4,,6,5 [4-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,MDV,Maldives,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,5,,,4,,6,5 [4-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MLI,Mali,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,5,,,4,,6,5 [4-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MRT,Mauritania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,5,,,4,,6,5 [4-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,NPL,Nepal,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,5,,,4,,6,5 [4-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,TON,Tonga,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,5,,,4,,6,5 [4-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,TCD,Chad,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,5,,,4,,7,5 [4-7],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GNB,Guinea-Bissau,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,5,,,4,,8,5 [4-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,BGD,Bangladesh,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,5,,,5,,6,5 [5-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SYR,Syrian Arab Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,5,,,5,,6,5 [5-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,TON,Tonga,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,5,,,5,,6,5 [5-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CUB,Cuba,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,50,,,44,,55,50 [44-55],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BWA,Botswana,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,50,,,47,,54,50 [47-54],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,ARG,Argentina,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,51,,,46,,55,51 [46-55],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,TKM,Turkmenistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,51,,,47,,56,51 [47-56],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ISR,Israel,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,51,,,49,,53,51 [49-53],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,NRU,Nauru,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,52,,,44,,60,52 [44-60],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,UKR,Ukraine,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,52,,,45,,59,52 [45-59],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ZAF,South Africa,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,52,,,47,,56,52 [47-56],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,KNA,Saint Kitts and Nevis,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,52,,,49,,54,52 [49-54],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CRI,Costa Rica,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,52,,,49,,55,52 [49-55],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,DOM,Dominican Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,52,,,49,,55,52 [49-55],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BOL,Bolivia (Plurinational State of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,53,,,46,,59,53 [46-59],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CPV,Cabo Verde,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,53,,,49,,57,53 [49-57],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,HRV,Croatia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,53,,,51,,54,53 [51-54],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,EST,Estonia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,53,,,51,,54,53 [51-54],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,VEN,Venezuela (Bolivarian Republic of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,54,,,42,,68,54 [42-68],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MKD,North Macedonia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,54,,,44,,63,54 [44-63],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ALB,Albania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,54,,,45,,63,54 [45-63],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,MYS,Malaysia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,54,,,46,,64,54 [46-64],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,CHE,Switzerland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,54,,,49,,58,54 [49-58],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SMR,San Marino,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,55,,,43,,67,55 [43-67],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,ECU,Ecuador,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,55,,,48,,62,55 [48-62],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,COL,Colombia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,55,,,53,,57,55 [53-57],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,FIN,Finland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,55,,,54,,56,55 [54-56],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MNE,Montenegro,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,56,,,43,,69,56 [43-69],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BHS,Bahamas,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,56,,,50,,61,56 [50-61],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,LVA,Latvia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,56,,,52,,60,56 [52-60],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,TTO,Trinidad and Tobago,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,56,,,53,,60,56 [53-60],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,COK,Cook Islands,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,57,,,41,,73,57 [41-73],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,UKR,Ukraine,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,57,,,48,,66,57 [48-66],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,JPN,Japan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,57,,,52,,61,57 [52-61],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,GRD,Grenada,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,57,,,53,,60,57 [53-60],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,EST,Estonia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,57,,,55,,58,57 [55-58],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,SGP,Singapore,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,57,,,55,,58,57 [55-58],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BRB,Barbados,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,57,,,56,,59,57 [56-59],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BRA,Brazil,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,58,,,48,,69,58 [48-69],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,GTM,Guatemala,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,58,,,50,,64,58 [50-64],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,JAM,Jamaica,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,58,,,53,,63,58 [53-63],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,KAZ,Kazakhstan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,58,,,55,,63,58 [55-63],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,NRU,Nauru,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,59,,,51,,67,59 [51-67],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,CZE,Czechia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,59,,,56,,62,59 [56-62],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,UZB,Uzbekistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,6,,,2,,10,6 [2-10],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ZMB,Zambia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,6,,,2,,11,6 [2-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,GUY,Guyana,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,6,,,3,,11,6 [3-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ERI,Eritrea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,6,,,3,,8,6 [3-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,COG,Congo,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,6,,,3,,9,6 [3-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,FSM,Micronesia (Federated States of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,6,,,3,,9,6 [3-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,UGA,Uganda,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,6,,,4,,7,6 [4-7],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,TCD,Chad,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,6,,,4,,8,6 [4-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GMB,Gambia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,6,,,4,,8,6 [4-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MLI,Mali,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,6,,,4,,8,6 [4-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MRT,Mauritania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,6,,,4,,8,6 [4-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CAF,Central African Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,6,,,4,,9,6 [4-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,IRQ,Iraq,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,6,,,4,,9,6 [4-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,LBR,Liberia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,6,,,4,,9,6 [4-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SLE,Sierra Leone,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,6,,,4,,9,6 [4-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BFA,Burkina Faso,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,6,,,5,,6,6 [5-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CMR,Cameroon,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,6,,,5,,6,6 [5-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,MDV,Maldives,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,6,,,5,,6,6 [5-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ROU,Romania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,6,,,5,,6,6 [5-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,TON,Tonga,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,6,,,5,,6,6 [5-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,NPL,Nepal,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,6,,,5,,7,6 [5-7],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SEN,Senegal,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,6,,,5,,8,6 [5-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,MAR,Morocco,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,6,,,6,,6,6 [6-6],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,ATG,Antigua and Barbuda,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,60,,,52,,69,60 [52-69],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,HND,Honduras,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,60,,,53,,67,60 [53-67],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,VCT,Saint Vincent and the Grenadines,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,60,,,57,,62,60 [57-62],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,QAT,Qatar,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,61,,,52,,69,61 [52-69],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,AND,Andorra,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,61,,,54,,68,61 [54-68],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,JPN,Japan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,61,,,55,,68,61 [55-68],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MDA,Republic of Moldova,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,61,,,56,,65,61 [56-65],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,PER,Peru,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,61,,,58,,64,61 [58-64],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ISR,Israel,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,61,,,59,,62,61 [59-62],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,URY,Uruguay,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,61,,,59,,62,61 [59-62],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BGR,Bulgaria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,61,,,59,,64,61 [59-64],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,GRC,Greece,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,61,,,59,,64,61 [59-64],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,UKR,Ukraine,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,62,,,51,,73,62 [51-73],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,BTN,Bhutan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,62,,,54,,68,62 [54-68],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,PLW,Palau,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,62,,,56,,69,62 [56-69],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,TKM,Turkmenistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,62,,,57,,66,62 [57-66],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BLZ,Belize,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,62,,,58,,66,62 [58-66],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,AUT,Austria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,62,,,60,,63,62 [60-63],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,MNG,Mongolia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,62,,,61,,64,62 [61-64],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BOL,Bolivia (Plurinational State of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,63,,,53,,73,63 [53-73],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,DMA,Dominica,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,63,,,59,,67,63 [59-67],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,KOR,Republic of Korea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,64,,,59,,68,64 [59-68],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SMR,San Marino,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,65,,,53,,77,65 [53-77],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,NLD,Netherlands (Kingdom of the),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,65,,,60,,70,65 [60-70],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,LCA,Saint Lucia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,65,,,62,,69,65 [62-69],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,FRA,France,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,65,,,64,,66,65 [64-66],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,DEU,Germany,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,65,,,64,,67,65 [64-67],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MCO,Monaco,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,66,,,54,,79,66 [54-79],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,KAZ,Kazakhstan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,66,,,59,,74,66 [59-74],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BHS,Bahamas,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,66,,,62,,69,66 [62-69],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,TTO,Trinidad and Tobago,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,66,,,62,,70,66 [62-70],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,KOR,Republic of Korea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,66,,,62,,71,66 [62-71],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BGR,Bulgaria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,66,,,63,,69,66 [63-69],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MKD,North Macedonia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,67,,,56,,76,67 [56-76],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ALB,Albania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,67,,,57,,76,67 [57-76],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,IRL,Ireland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,67,,,61,,73,67 [61-73],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,MEX,Mexico,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,67,,,61,,73,67 [61-73],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,SGP,Singapore,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,67,,,64,,69,67 [64-69],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,THA,Thailand,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,67,,,64,,70,67 [64-70],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ISR,Israel,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,67,,,65,,68,67 [65-68],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SRB,Serbia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,67,,,65,,68,67 [65-68],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,LUX,Luxembourg,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,67,,,66,,67,67 [66-67],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,NOR,Norway,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,67,,,66,,68,67 [66-68],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,AND,Andorra,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,68,,,59,,76,68 [59-76],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,HND,Honduras,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,68,,,61,,74,68 [61-74],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ISL,Iceland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,68,,,67,,69,68 [67-69],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,PAN,Panama,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,69,,,59,,76,69 [59-76],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BLR,Belarus,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,69,,,62,,76,69 [62-76],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,COL,Colombia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,69,,,64,,74,69 [64-74],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,GTM,Guatemala,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,69,,,64,,74,69 [64-74],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,KOR,Republic of Korea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,69,,,64,,74,69 [64-74],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,SGP,Singapore,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,69,,,66,,71,69 [66-71],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SWZ,Eswatini,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,7,,,3,,12,7 [3-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,DJI,Djibouti,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,7,,,4,,11,7 [4-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GIN,Guinea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,7,,,4,,12,7 [4-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,RWA,Rwanda,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,7,,,4,,12,7 [4-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,COD,Democratic Republic of the Congo,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,7,,,5,,11,7 [5-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SSD,South Sudan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,7,,,5,,11,7 [5-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,OMN,Oman,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,7,,,5,,9,7 [5-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,IDN,Indonesia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,7,,,6,,7,7 [6-7],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ALB,Albania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,7,,,6,,8,7 [6-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BFA,Burkina Faso,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,7,,,6,,8,7 [6-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,BGD,Bangladesh,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,7,,,7,,7,7 [7-7],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,HTI,Haiti,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,7,,,7,,8,7 [7-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,KEN,Kenya,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,7,,,7,,8,7 [7-8],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,JPN,Japan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,70,,,59,,80,70 [59-80],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,ECU,Ecuador,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,70,,,67,,72,70 [67-72],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,AUS,Australia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,70,,,67,,74,70 [67-74],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,BRN,Brunei Darussalam,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,70,,,69,,71,70 [69-71],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,GBR,United Kingdom of Great Britain and Northern Ireland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,70,,,69,,71,70 [69-71],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,AND,Andorra,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,71,,,62,,80,71 [62-80],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,NIC,Nicaragua,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,71,,,65,,77,71 [65-77],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,JAM,Jamaica,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,71,,,67,,76,71 [67-76],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BGR,Bulgaria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,71,,,68,,74,71 [68-74],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,URY,Uruguay,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,71,,,69,,73,71 [69-73],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,ATG,Antigua and Barbuda,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,72,,,64,,80,72 [64-80],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,GRD,Grenada,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,72,,,67,,76,72 [67-76],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,DNK,Denmark,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,72,,,69,,74,72 [69-74],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MDA,Republic of Moldova,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,73,,,67,,79,73 [67-79],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,CYP,Cyprus,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,73,,,70,,76,73 [70-76],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,NZL,New Zealand,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,73,,,70,,76,73 [70-76],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,AND,Andorra,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,74,,,64,,85,74 [64-85],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,COL,Colombia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,74,,,68,,81,74 [68-81],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,NLD,Netherlands (Kingdom of the),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,74,,,69,,78,74 [69-78],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,DMA,Dominica,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,74,,,69,,79,74 [69-79],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,LTU,Lithuania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,74,,,70,,79,74 [70-79],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,VCT,Saint Vincent and the Grenadines,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,74,,,72,,77,74 [72-77],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MCO,Monaco,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,75,,,63,,88,75 [63-88],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,HND,Honduras,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,75,,,69,,81,75 [69-81],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,HUN,Hungary,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,75,,,70,,79,75 [70-79],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,PER,Peru,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,75,,,71,,81,75 [71-81],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CHL,Chile,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,75,,,74,,77,75 [74-77],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ESP,Spain,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,76,,,71,,81,76 [71-81],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CRI,Costa Rica,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,76,,,72,,79,76 [72-79],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,RUS,Russian Federation,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,76,,,72,,80,76 [72-80],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,KNA,Saint Kitts and Nevis,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,76,,,74,,79,76 [74-79],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,USA,United States of America,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,76,,,74,,79,76 [74-79],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BHS,Bahamas,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,76,,,75,,77,76 [75-77],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SVN,Slovenia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,76,,,75,,78,76 [75-78],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MKD,North Macedonia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,77,,,66,,85,77 [66-85],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,PAN,Panama,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,77,,,68,,83,77 [68-83],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,MEX,Mexico,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,77,,,69,,83,77 [69-83],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,THA,Thailand,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,77,,,71,,83,77 [71-83],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CRI,Costa Rica,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,77,,,73,,80,77 [73-80],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SVK,Slovakia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,77,,,74,,79,77 [74-79],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,CZE,Czechia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,77,,,74,,80,77 [74-80],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CRI,Costa Rica,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,78,,,74,,81,78 [74-81],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,CYP,Cyprus,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,78,,,74,,81,78 [74-81],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,ARG,Argentina,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,78,,,75,,81,78 [75-81],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BEL,Belgium,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,78,,,76,,79,78 [76-79],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,GBR,United Kingdom of Great Britain and Northern Ireland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,78,,,77,,79,78 [77-79],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SWE,Sweden,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,78,,,77,,80,78 [77-80],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,DOM,Dominican Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,79,,,75,,83,79 [75-83],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,SLV,El Salvador,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,79,,,75,,83,79 [75-83],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MLT,Malta,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,79,,,75,,83,79 [75-83],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,LCA,Saint Lucia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,79,,,76,,81,79 [76-81],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CHL,Chile,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,79,,,77,,82,79 [77-82],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,NOR,Norway,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,79,,,78,,80,79 [78-80],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,CHE,Switzerland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,79,,,78,,81,79 [78-81],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,TKM,Turkmenistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,8,,,4,,13,8 [4-13],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,BDI,Burundi,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,8,,,5,,11,8 [5-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,ERI,Eritrea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,8,,,5,,11,8 [5-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,NER,Niger,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,8,,,5,,11,8 [5-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,YEM,Yemen,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,8,,,5,,11,8 [5-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,NGA,Nigeria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,8,,,5,,12,8 [5-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,TGO,Togo,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,8,,,5,,12,8 [5-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,TZA,United Republic of Tanzania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,8,,,5,,12,8 [5-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,VUT,Vanuatu,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,8,,,5,,12,8 [5-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GAB,Gabon,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,8,,,5,,13,8 [5-13],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GNB,Guinea-Bissau,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,8,,,6,,11,8 [6-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,JOR,Jordan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,8,,,6,,11,8 [6-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,CAF,Central African Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,8,,,6,,12,8 [6-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SLE,Sierra Leone,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,8,,,6,,12,8 [6-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,OMN,Oman,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,8,,,6,,9,8 [6-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,OMN,Oman,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,8,,,6,,9,8 [6-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,OMN,Oman,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,8,,,6,,9,8 [6-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,UGA,Uganda,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,8,,,6,,9,8 [6-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,SEN,Senegal,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,8,,,7,,10,8 [7-10],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MDG,Madagascar,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,8,,,7,,9,8 [7-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SAU,Saudi Arabia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,8,,,7,,9,8 [7-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,SLB,Solomon Islands,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,8,,,8,,9,8 [8-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,NIC,Nicaragua,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,80,,,73,,86,80 [73-86],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,PLW,Palau,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,80,,,73,,89,80 [73-89],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,LTU,Lithuania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,80,,,75,,85,80 [75-85],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,PRT,Portugal,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,80,,,75,,85,80 [75-85],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,POL,Poland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,80,,,76,,84,80 [76-84],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,FRA,France,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,80,,,78,,81,80 [78-81],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SMR,San Marino,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,81,,,70,,92,81 [70-92],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,COL,Colombia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,81,,,72,,89,81 [72-89],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,PLW,Palau,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,81,,,73,,90,81 [73-90],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MDA,Republic of Moldova,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,81,,,74,,88,81 [74-88],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ITA,Italy,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,81,,,75,,88,81 [75-88],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BLR,Belarus,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,81,,,76,,86,81 [76-86],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ISL,Iceland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,81,,,80,,82,81 [80-82],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CUB,Cuba,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,82,,,76,,87,82 [76-87],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,IRL,Ireland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,82,,,77,,86,82 [77-86],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,ARG,Argentina,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,82,,,78,,86,82 [78-86],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SVK,Slovakia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,82,,,79,,84,82 [79-84],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,USA,United States of America,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,82,,,79,,84,82 [79-84],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,CYP,Cyprus,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,82,,,79,,86,82 [79-86],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CAN,Canada,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,82,,,80,,83,82 [80-83],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BEL,Belgium,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,82,,,81,,83,82 [81-83],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,TUR,Türkiye,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,82,,,81,,84,82 [81-84],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,PRY,Paraguay,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,83,,,75,,90,83 [75-90],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ESP,Spain,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,83,,,77,,88,83 [77-88],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,KNA,Saint Kitts and Nevis,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,83,,,80,,85,83 [80-85],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BRB,Barbados,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,83,,,82,,84,83 [82-84],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,ATG,Antigua and Barbuda,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,84,,,75,,91,84 [75-91],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,PRY,Paraguay,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,84,,,77,,92,84 [77-92],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,PRT,Portugal,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,84,,,78,,89,84 [78-89],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,HUN,Hungary,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,84,,,78,,90,84 [78-90],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,AUS,Australia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,84,,,80,,88,84 [80-88],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MCO,Monaco,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,85,,,71,,98,85 [71-98],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,DMA,Dominica,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,85,,,79,,91,85 [79-91],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,RUS,Russian Federation,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,85,,,81,,88,85 [81-88],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,DOM,Dominican Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,85,,,81,,89,85 [81-89],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,DNK,Denmark,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,85,,,82,,87,85 [82-87],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,JAM,Jamaica,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,85,,,82,,89,85 [82-89],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,DEU,Germany,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,85,,,83,,87,85 [83-87],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,EST,Estonia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,85,,,84,,87,85 [84-87],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,PRY,Paraguay,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,86,,,78,,94,86 [78-94],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,LTU,Lithuania,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,86,,,81,,92,86 [81-92],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MLT,Malta,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,86,,,82,,89,86 [82-89],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,CZE,Czechia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,86,,,83,,90,86 [83-90],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,HRV,Croatia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,86,,,84,,88,86 [84-88],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BEL,Belgium,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,86,,,85,,88,86 [85-88],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,PAN,Panama,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,87,,,79,,93,87 [79-93],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ITA,Italy,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,87,,,80,,93,87 [80-93],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CUB,Cuba,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,87,,,80,,94,87 [80-94],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,GRD,Grenada,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,87,,,81,,92,87 [81-92],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SVK,Slovakia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,87,,,83,,90,87 [83-90],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,SLV,El Salvador,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,87,,,83,,91,87 [83-91],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,GRC,Greece,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,87,,,83,,91,87 [83-91],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,NZL,New Zealand,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,87,,,84,,90,87 [84-90],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,POL,Poland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,87,,,84,,91,87 [84-91],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CAN,Canada,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,87,,,85,,88,87 [85-88],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,AUT,Austria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,87,,,85,,89,87 [85-89],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,LUX,Luxembourg,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,87,,,86,,89,87 [86-89],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,MEX,Mexico,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,88,,,79,,94,88 [79-94],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,PRT,Portugal,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,88,,,81,,94,88 [81-94],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ESP,Spain,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,88,,,81,,95,88 [81-95],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SVN,Slovenia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,88,,,86,,90,88 [86-90],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,USA,United States of America,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,88,,,86,,90,88 [86-90],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,NIC,Nicaragua,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,89,,,82,,95,89 [82-95],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,PER,Peru,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,89,,,82,,95,89 [82-95],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,ARG,Argentina,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,89,,,84,,94,89 [84-94],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,LVA,Latvia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,89,,,85,,93,89 [85-93],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,VCT,Saint Vincent and the Grenadines,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,89,,,86,,92,89 [86-92],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,GBR,United Kingdom of Great Britain and Northern Ireland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,89,,,86,,92,89 [86-92],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,CHE,Switzerland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,89,,,87,,90,89 [87-90],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,DEU,Germany,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,89,,,87,,91,89 [87-91],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,NOR,Norway,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,89,,,87,,92,89 [87-92],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,KNA,Saint Kitts and Nevis,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,89,,,87,,92,89 [87-92],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BRB,Barbados,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,89,,,88,,91,89 [88-91],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,LUX,Luxembourg,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,89,,,88,,91,89 [88-91],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,KIR,Kiribati,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,9,,,5,,13,9 [5-13],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,TUN,Tunisia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,9,,,5,,13,9 [5-13],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GNQ,Equatorial Guinea,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,9,,,5,,14,9 [5-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,GEO,Georgia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,9,,,5,,14,9 [5-14],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,GMB,Gambia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,9,,,6,,12,9 [6-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,MWI,Malawi,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,9,,,6,,12,9 [6-12],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,COD,Democratic Republic of the Congo,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,9,,,6,,13,9 [6-13],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,LBR,Liberia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,9,,,6,,13,9 [6-13],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,TJK,Tajikistan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,9,,,7,,10,9 [7-10],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,AZE,Azerbaijan,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,9,,,7,,11,9 [7-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,FSM,Micronesia (Federated States of),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,9,,,7,,11,9 [7-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,COM,Comoros,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last year,TIMEPERIOD_TIMEPERIOD_LAST01YEAR,,,,9,,,8,,10,9 [8-10],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,IRQ,Iraq,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,9,,,8,,11,9 [8-11],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EMR,Eastern Mediterranean,Country,SAU,Saudi Arabia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,9,,,8,,9,9 [8-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AFR,Africa,Country,COM,Comoros,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,9,,,9,,10,9 [9-10],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,FJI,Fiji,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last three years,TIMEPERIOD_TIMEPERIOD_LAST03YEARS,,,,9,,,9,,10,9 [9-10],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,SEAR,South-East Asia,Country,IDN,Indonesia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,9,,,9,,9,9 [9-9],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,GRC,Greece,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,90,,,86,,94,90 [86-94],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,BLR,Belarus,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,90,,,87,,94,90 [87-94],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,AUT,Austria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,90,,,88,,92,90 [88-92],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,FIN,Finland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,90,,,89,,91,90 [89-91],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,HRV,Croatia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,90,,,89,,92,90 [89-92],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CUB,Cuba,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,91,,,83,,99,91 [83-99],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CHL,Chile,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,91,,,86,,95,91 [86-95],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,LUX,Luxembourg,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,91,,,90,,92,91 [90-92],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,CAN,Canada,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,91,,,90,,93,91 [90-93],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ITA,Italy,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,92,,,85,,99,92 [85-99],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,DOM,Dominican Republic,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,92,,,88,,96,92 [88-96],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,MLT,Malta,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,92,,,89,,95,92 [89-95],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,LCA,Saint Lucia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,92,,,90,,94,92 [90-94],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SRB,Serbia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,92,,,90,,94,92 [90-94],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,HUN,Hungary,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,93,,,85,,100,93 [85-100],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,GRC,Greece,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,93,,,88,,98,93 [88-98],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,RUS,Russian Federation,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,93,,,89,,97,93 [89-97],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SWE,Sweden,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in the last five years,TIMEPERIOD_TIMEPERIOD_LAST05YEARS,,,,93,,,90,,95,93 [90-95],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,URY,Uruguay,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,93,,,91,,94,93 [91-94],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,AUT,Austria,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,93,,,91,,95,93 [91-95],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,DEU,Germany,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,93,,,91,,95,93 [91-95],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,ISL,Iceland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,93,,,92,,95,93 [92-95],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,IRL,Ireland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,94,,,88,,99,94 [88-99],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,FRA,France,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,94,,,92,,96,94 [92-96],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,AUS,Australia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,95,,,91,,98,95 [91-98],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,POL,Poland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,95,,,91,,98,95 [91-98],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,SLV,El Salvador,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,95,,,92,,99,95 [92-99],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,HRV,Croatia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,95,,,93,,96,95 [93-96],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,SVN,Slovenia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,95,,,94,,97,95 [94-97],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,TUR,Türkiye,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,96,,,92,,99,96 [92-99],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,FIN,Finland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,96,,,93,,100,96 [93-100],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,AMR,Americas,Country,BRB,Barbados,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,96,,,93,,98,96 [93-98],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,DNK,Denmark,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,96,,,93,,99,96 [93-99],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,CZE,Czechia,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,97,,,92,,102,97 [92-102],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,WPR,Western Pacific,Country,NZL,New Zealand,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,97,,,93,,99,97 [93-99],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,NLD,Netherlands (Kingdom of the),Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,98,,,95,,101,98 [95-101],,,EN,2022-09-18T22:00:00.000Z
NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%),numeric,EUR,Europe,Country,CHE,Switzerland,Year,2019,true,Sex,Female,SEX_FMLE,Age Group,30-49 years,AGEGROUP_YEARS30-49,Time period,in lifetime,TIMEPERIOD_TIMEPERIOD_EVER_LIFETIME,,,,98,,,96,,99,98 [96-99],,,EN,2022-09-18T22:00:00.000Z
